Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 174 results for "mirati"

Mirati Therapeutics Reports Financial Results And Provides Business Update For The Second Quarter 2016
BioSpace

BRIEF-Broadfin Capital, LLC reports 5.02 pct passive stake in ...

Aug 10 Mirati Therapeutics Inc * Broadfin Capital, LLC reports 5.02 pct passive stake in Mirati Therapeutics as of August 8, 2016 - SEC Filing Source - bit.ly/2aMdcIv Further company coverage: Our top photos from the last 24 hours. ... Reuters UK, 2 weeks ago
Mirati Therapeutics reports Q2 EPS ($1.11), consensus ($1.15) Pettinga Financial Advisors, 3 weeks ago
[x]  

19 images for mirati

Before It's News, 1 week ago
Asian Hospital & Healthcare Management, 3 weeks ago
Yahoo! Singapore, 3 weeks ago
Before It's News, 3 weeks ago
ADVFN India, 2 months ago
FOXBusiness.com, 2 months ago
FOXBusiness.com, 2 months ago
Schaeffers Research, 2 months ago
Nasdaq, 2 months ago
Motley Fool, 2 months ago

Mirati Therapeutics Inc. (MRTX) Earns Neutral Rating from Piper Jaffray Cos.

Piper Jaffray Cos. reiterated their neutral rating on shares of Mirati Therapeutics Inc. (NASDAQ:MRTX) in a report issued on Monday morning. Piper Jaffray Cos. currently has a $7.00 price target on the stock, down from their previous price target of ...
 SleekMoney2 weeks ago Mirati Therapeutics Inc. (MRTX) Given Neutral Rating at Piper Jaffray Cos.  Zolmax News2 weeks ago Mirati Therapeutics, Inc. (MRTX) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS  Mideast Time2 weeks ago Mirati Therapeutics beats by $0.04  Seeking Alpha3 weeks ago
[x]  

SC 13G - Mirati Therapeutics, Inc. (0001576263) (Subject)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals SEC Accession No. 0000919574-16-014509 Filing Date 2016-08-10 2016-08-10 15:01:54 Filing Date Changed 2016-08-10 Document Format Files Mailing Address ...
 SEC Filings2 weeks ago SC 13G - Broadfin Capital, LLC (0001511901) (Filed by)  SEC Filings2 weeks ago

Stocks Hitting 52-Week Lows

Mirati Therapeutics, Inc. (NASDAQ: MRTX ) shares touched a new 52-week low of $6.54. Mirati Therapeutics shares have dropped 78.59 percent over the past 52 weeks, while the S&P 500 index has declined 1.84 percent in the same period. Adamis ...
 Benzinga.com2 months ago

Mirati Therapeutics Inc. (NASDAQ:MRTX) Given Average Recommendation of Buy by Brokerages

Shares of Mirati Therapeutics Inc. (NASDAQ:MRTX) have been given a consensus recommendation of Buy by the ten brokerages that are presently covering the company. Four equities research analysts have rated the stock with a hold recommendation and six ...
 Mideast Time1 week ago Piper Jaffray Cos. Reiterates Neutral Rating for Mirati Therapeutics Inc. (MRTX)  WKRB News2 weeks ago Piper Jaffray Cos. Reaffirms Neutral Rating for Mirati Therapeutics, Inc. (MRTX)  American Banking News2 weeks ago Aviva Holdings Ltd. Purchases 1,023,501 Shares of Mirati Therapeutics Inc. (MRTX)  WKRB News1 month ago
[x]  
American Banking News - Forex

Weekly Analysts Ratings Updates for Mirati Therapeutics (MRTX)

Mirati Therapeutics (NASDAQ: MRTX) recently received a number of ratings updates from brokerages and research firms: 6/6/2016 Mirati Therapeutics had its price target lowered by analysts at Wedbush from $29.00 to $27.00. They now have an ...
 American Banking News - Earnings2 months ago Weekly Investment Analysts Ratings Changes for Mirati Therapeutics (MRTX)  SleekMoney2 months ago Investment Analysts Upgrades for August, 6th (IDCC, IOSP, ITI, JRVR, KOP, LINC, LOCK, MRTX, NMIH, NSM)  American Banking News - Forex3 weeks ago

MIRATI THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)

 4 Traders1 month ago MIRATI THERAPEUTICS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)  4 Traders2 months ago

Cormorant Asset Management LLC Has $10,601,000 Position in Mirati Therapeutics Inc. (MRTX)

Cormorant Asset Management LLC maintained its position in shares of Mirati Therapeutics Inc. (NASDAQ:MRTX) during the first quarter, Holdings Channel reports. The firm owned 495,356 shares of the company's stock at the end of the first quarter.
 SleekMoney1 month ago Sabby Management LLC Boosts Stake in Mirati Therapeutics Inc. (MRTX)  WKRB News1 month ago Franklin Resources Inc. Has $13,140,000 Position in Mirati Therapeutics, Inc. (MRTX)  SleekMoney1 month ago Royal Bank of Canada Raises Stake in Mirati Therapeutics, Inc. (MRTX)  Ticker Report2 months ago

First Week of MRTX August 19th Options Trading

at 10:55 AM EDT Investors in Mirati Therapeutics Inc (MRTX) saw new options become available this week, for the August 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRTX options chain for the new August ...
 Wall Street Select2 months ago
[x]  

6 Biopharma Stocks Under $10 Per Share Expected to Climb

By Mark Terry , BioSpace.com Breaking News Staff Buy low and sell high is pretty much central dogma for stocks. Here are six biopharma stocks currently selling for under $10 per share that have the potential to climb high. Mirati Therapeutics ...
 BioSpace2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less